These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22056621)

  • 21. RAIDD mutations underlie the pathogenesis of thin lissencephaly (TLIS).
    Ha HJ; Park HH
    PLoS One; 2018; 13(10):e0205042. PubMed ID: 30281648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional connection between p53 and caspase-2 is essential for apoptosis induced by DNA damage.
    Vakifahmetoglu H; Olsson M; Orrenius S; Zhivotovsky B
    Oncogene; 2006 Sep; 25(41):5683-92. PubMed ID: 16652156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antitumor effect of TAT-oxygen-dependent degradation-caspase-3 fusion protein specifically stabilized and activated in hypoxic tumor cells.
    Harada H; Hiraoka M; Kizaka-Kondoh S
    Cancer Res; 2002 Apr; 62(7):2013-8. PubMed ID: 11929818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Caspase-2 activation in the absence of PIDDosome formation.
    Manzl C; Krumschnabel G; Bock F; Sohm B; Labi V; Baumgartner F; Logette E; Tschopp J; Villunger A
    J Cell Biol; 2009 Apr; 185(2):291-303. PubMed ID: 19364921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The tumor-modulatory effects of Caspase-2 and Pidd1 do not require the scaffold protein Raidd.
    Peintner L; Dorstyn L; Kumar S; Aneichyk T; Villunger A; Manzl C
    Cell Death Differ; 2015 Nov; 22(11):1803-11. PubMed ID: 25857265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Introduction of an N-terminal peptide of S100C/A11 into human cells induces apoptotic cell death.
    Makino E; Sakaguchi M; Iwatsuki K; Huh NH
    J Mol Med (Berl); 2004 Sep; 82(9):612-20. PubMed ID: 15241500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuronal caspase 2 activity and function requires RAIDD, but not PIDD.
    Ribe EM; Jean YY; Goldstein RL; Manzl C; Stefanis L; Villunger A; Troy CM
    Biochem J; 2012 Jun; 444(3):591-9. PubMed ID: 22515271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Caspase-2: the orphan caspase.
    Bouchier-Hayes L; Green DR
    Cell Death Differ; 2012 Jan; 19(1):51-7. PubMed ID: 22075987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Centriolar distal appendages activate the centrosome-PIDDosome-p53 signalling axis via ANKRD26.
    Burigotto M; Mattivi A; Migliorati D; Magnani G; Valentini C; Roccuzzo M; Offterdinger M; Pizzato M; Schmidt A; Villunger A; Maffini S; Fava LL
    EMBO J; 2021 Feb; 40(4):e104844. PubMed ID: 33350486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transduction of human catalase mediated by an HIV-1 TAT protein basic domain and arginine-rich peptides into mammalian cells.
    Jin LH; Bahn JH; Eum WS; Kwon HY; Jang SH; Han KH; Kang TC; Won MH; Kang JH; Cho SW; Park J; Choi SY
    Free Radic Biol Med; 2001 Dec; 31(11):1509-19. PubMed ID: 11728823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PIDDosome expression and the role of caspase-2 activation for chemotherapy-induced apoptosis in RCCs.
    Heikaus S; Pejin I; Gabbert HE; Ramp U; Mahotka C
    Cell Oncol; 2010; 32(1-2):29-42. PubMed ID: 20208132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of NF-kappa B activity by a membrane-transducing mutant of I kappa B alpha.
    Kabouridis PS; Hasan M; Newson J; Gilroy DW; Lawrence T
    J Immunol; 2002 Sep; 169(5):2587-93. PubMed ID: 12193729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TAT-OSBP-1-MKK6(E), a novel TAT-fusion protein with high selectivity for human ovarian cancer, exhibits anti-tumor activity.
    Zhong J; Kang J; Wang X; Jiang W; Liao H; Yuan J
    Med Oncol; 2015 Apr; 32(4):118. PubMed ID: 25782870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of Upregulated P53-Induced Death Domain Protein in Retinal Ganglion Cells Apoptosis After Optic Nerve Crush.
    Zhang M; Chen L; Xu F; Jiang L; Yan W; Kunwar B; Tang F; Yang K; Shen C; Huang H; Lv J; Qin C; Wu X; Zeng S; Li M; Zhong S; Chen Q
    Curr Mol Med; 2019; 20(1):51-59. PubMed ID: 31533600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tat-antioxidant 1 protects against stress-induced hippocampal HT-22 cells death and attenuate ischaemic insult in animal model.
    Kim SM; Hwang IK; Yoo DY; Eum WS; Kim DW; Shin MJ; Ahn EH; Jo HS; Ryu EJ; Yong JI; Cho SW; Kwon OS; Lee KW; Cho YS; Han KH; Park J; Choi SY
    J Cell Mol Med; 2015 Jun; 19(6):1333-45. PubMed ID: 25781353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of antigen-specific CTL by recombinant HIV trans-activating fusion protein-pulsed human monocyte-derived dendritic cells.
    Tanaka Y; Dowdy SF; Linehan DC; Eberlein TJ; Goedegebuure PS
    J Immunol; 2003 Feb; 170(3):1291-8. PubMed ID: 12538688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PIDD mediates NF-kappaB activation in response to DNA damage.
    Janssens S; Tinel A; Lippens S; Tschopp J
    Cell; 2005 Dec; 123(6):1079-92. PubMed ID: 16360037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stabilizing the eIF4G1 α-helix increases its binding affinity with eIF4E: implications for peptidomimetic design strategies.
    Brown CJ; Lim JJ; Leonard T; Lim HC; Chia CS; Verma CS; Lane DP
    J Mol Biol; 2011 Jan; 405(3):736-53. PubMed ID: 21094167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activity of synthetic peptides from the Tat protein of human immunodeficiency virus type 1.
    Dis Markers; 1990; 8(2):107. PubMed ID: 2201474
    [No Abstract]   [Full Text] [Related]  

  • 40. Recombinant fusion proteins TAT-Mu, Mu and Mu-Mu mediate efficient non-viral gene delivery.
    Rajagopalan R; Xavier J; Rangaraj N; Rao NM; Gopal V
    J Gene Med; 2007 Apr; 9(4):275-86. PubMed ID: 17397090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.